Sylvie Fromont und Nathalie Bouquier - Info zur Person

(1 - 13 von 14

)

Aptamer-Derived Peptides as Potent Inhibitors of the ...Cell

www.cell.com

von N Bouquier · · Zitiert von: 51 — Nathalie Bouquier,1,2 Sylvie Fromont,1,2 Jean-Christophe Zeeh,3 Camille Auziol,1,2 Pauline Larrousse,1,2. Bruno Robert,4,5,6,7 Mahel Zeghouf ...

Rational Drug Design - Zheng Yi (Curatore)hoepli.it

www.hoepli.it

Nathalie Bouquier, Sylvie Fromont, Anne Debant and Susanne Schmidt. 9. A Screening Strategy for Trapping the Inactive Conformer of a Dimeric Enzyme with a ...

Jean-Christophe Zeeh | 839 Citations | Related Authors

typeset.io

Nathalie Bouquier 1, Nathalie Bouquier 2, Sylvie Fromont 1, Sylvie Fromont 2, Jean-Christophe Zeeh 1, Camille Auziol 2, Camille Auziol 1, Pauline Larrousse ... › authors

Rational Drug Design - Zheng Yi (Curatore) - Hoepli

www.hoepli.it

Nathalie Bouquier, Sylvie Fromont, Anne Debant and Susanne Schmidt. 9. A Screening Strategy for Trapping the Inactive Conformer of a Dimeric Enzyme with a ... › libro › ratio...

Aptamer-derived peptides as potent inhibitors of the ...Archive ouverte HAL

hal.science

von N Bouquier · · Zitiert von: 51 — Aptamer-derived peptides as potent inhibitors of the oncogenic RhoGEF Tgat. Nathalie Bouquier 1Sylvie Fromont 1 Jean-Christophe Zeeh 2 Camille Auziol

Pauline Larrousse – ScienceOpen

www.scienceopen.com

Aptamer-derived peptides as potent inhibitors of the oncogenic RhoGEF Tgat. Authors: Nathalie Bouquier, Sylvie Fromont, Jean-Christophe Zeeh …

Rational Drug Design | SpringerLink

link.springer.com

von Y Zheng · Zitiert von: 4 — Random Mutagenesis of Peptide Aptamers as an Optimization Strategy for Inhibitor Screening. Nathalie Bouquier, Sylvie Fromont, Anne Debant, Susanne Schmidt. › book

Aptamer-derived peptides as potent inhibitors of the ...Inserm

www.hal.inserm.fr

von N Bouquier · · Zitiert von: 51 — Nathalie Bouquier, Sylvie Fromont, Jean-Christophe Zeeh, Camille Auziol, Pauline Larrousse, et al.. Aptamer-derived peptides as potent inhibitors of the ...

Aptamer-derived peptides as potent inhibitors of the oncogenic RhoGEF...

hal.archives-ouvertes.fr

Aptamer-derived peptides as potent inhibitors of the oncogenic RhoGEF Tgat. Nathalie Bouquier 1Sylvie Fromont 1 Jean-Christophe Zeeh 2 Camille Auziol › ha...

Random mutagenesis of peptide aptamers as an ...National Institutes of Health (.gov)

pubmed.ncbi.nlm.nih.gov

von N Bouquier · · Zitiert von: 3 — Authors. Nathalie Bouquier , Sylvie Fromont, Anne Debant, Susanne Schmidt. Affiliation. 1 Centre de Recherche de Biochimie Macromoléculaire, CNRS-UMR 5237, ...

Random Mutagenesis of Peptide Aptamers as an Optimization Strategy...

experiments.springernature.com

Random Mutagenesis of Peptide Aptamers as an Optimization Strategy for Inhibitor Screening. Authors: Nathalie Bouquier 2 ,. Sylvie Fromont 1 ,. Anne Debant ...

Rational Drug Design - Geneeskundeboek

www.geneeskundeboek.nl

... of Peptide Aptamers As An Optimization Strategy for Inhibitor Screening Nathalie Bouquier, Sylvie Fromont, Anne Debant and Susanne Schmidt 9. › ...

Alle Infos zum Namen "Sylvie Fromont"

Verwandte Suchanfragen zu Sylvie Fromont

Nathalie Bouquier
Susanne Schmidt

Personen
Vorname "Sylvie" (2806)
Name "Fromont" (25)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sylvie Fromont und Nathalie Bouquier Person-Info